mtuscan@cooley.com
Dr. Michael Tuscan focuses on the development, execution and enforcement of worldwide market exclusivity strategies for products and technologies that are the core asset of biotechnology companies of all sizes. Mike is partner in charge of the Washington DC office and is the former co-chair of Cooley's patent counseling and prosecution practice group.
Download full bio
Forbius Agrees to Sell to Bristol Myers Squibb
Iconic Therapeutics Series C Financing
FibroGen Closes Largest Biotech IPO in 12 Years
T2 Biosystems IPO
Adamas Pharmaceuticals Initial Public Offering
View all
Intellectual Property
Patent Counseling & Prosecution – Life Sciences
Patent Office Litigation
Life Sciences
Medtech
Georgetown University Law CenterJD, 1998
Emory UniversityPhD, Molecular Biology1991
Illinois State UniversityMS, Genetics1986
Carroll CollegeBS, 1984
District of Columbia
Maryland
Registered to practice before the United States Patent & Trademark Office (USPTO)
Law Firms Plant Feet In DC As Regulatory, IP Landscape Shifts November 23, 2021
Legal 500 US 2021 Highlights Cooley July 19, 2021
Forbius Agrees to Sell to Bristol Myers Squibb August 25, 2020
Best Lawyers in America: Technology Law
Legal 500: Top Lawyer for Life Sciences and Patent Prosecution
Managing Intellectual Property: IP Star
Who's Who Legal: Top Patent Lawyer
Best Lawyers: Leading IP Lawyer
+1 202 842 7802
Locations